UWB Crest

cost-CM1102

About

The aim of the Action is to develop novel nanoscale glycoconjugates suitable for biomedical applications which will be achieved through the following objectives (list of working group participants):

  1. Develop new synthetic methods that will allow the practical production of glycoconjugates for nanoscience applications

  2. Gain new fundamental understanding of multivalent self-assembly and translate these findings into biomedical and industrial nanotechnology applications

  3. Develop non-invasive diagnostic/prognostic tools for cancer and diseases and develop new nano-devices for targeting brain tissues

  4. Develop new immunostimulant species for immunological therapies Develop new anti-adhesion methods for treating pathogenic infections